BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32685004)

  • 1. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
    Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
    Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
    [No Abstract]   [Full Text] [Related]  

  • 2. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
    Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer.
    Ye G; Huang K; Yu J; Zhao L; Zhu X; Yang Q; Li W; Jiang Y; Zhuang B; Liu H; Shen Z; Wang D; Yan L; Zhang L; Zhou H; Hu Y; Deng H; Liu H; Li G; Qi X
    Theranostics; 2017; 7(13):3338-3353. PubMed ID: 28900514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
    Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
    Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia.
    Fang X; Bai Y; Zhang L; Ding S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
    Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
    Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.
    Du S; Yang Z; Lu X; Yousuf S; Zhao M; Li W; Miao J; Wang X; Yu H; Zhu X; Chen H; Shi L; Xu E; Xia X; Guan W
    Oncogene; 2021 Sep; 40(38):5764-5779. PubMed ID: 34341514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway.
    Li Y; Liu C; Zhang X; Huang X; Liang S; Xing F; Tian H
    Br J Cancer; 2022 Jun; 126(12):1684-1694. PubMed ID: 35194191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/β-catenin pathway.
    Wang L; Li B; Yi X; Xiao X; Zheng Q; Ma L
    Cell Prolif; 2021 Mar; 54(3):e12981. PubMed ID: 33458917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
    Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
    Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
    Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
    Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
    Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
    Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
    Xu Y; Feng Y; Sun Z; Li Q
    Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
    Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
    Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
    Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
    Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population.
    Liu Y; Chen H; Zheng P; Zheng Y; Luo Q; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):125. PubMed ID: 28893318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.